CN Patent

CN117222403A — 索托拉西布制剂

Assigned to Amgen Inc · Expires 2023-12-12 · 2y expired

What this patent protects

本披露提供了包含索托拉西布(1)、稀释剂、崩解剂和润滑剂的制剂。

USPTO Abstract

本披露提供了包含索托拉西布(1)、稀释剂、崩解剂和润滑剂的制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN117222403A
Jurisdiction
CN
Classification
—
Expires
2023-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Amgen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.